Please login to the form below

Not currently logged in
Email:
Password:

Creabilis

This page shows the latest Creabilis news and features for those working in and with pharma, biotech and healthcare.

UK biotech gains further £47.2m from Biomedical Catalyst funding

UK biotech gains further £47.2m from Biomedical Catalyst funding

For example, clinical-stage biotech company Creabilis leveraged additional capital alongside its award to fund a large clinical trial in atopic dermatitis.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    175. Creabilis (UK). Sienna. Acquisition. Portfolio of first-in-class topical. 150. Global rights unless stated. ... Deal structure. Comments. Creabilis. Sienna Biopharmaceuticals. $150m. Undisclosed upfront payments. Regulatory and commercial milestone

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics